Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 maternal safety and immunogenicity trial of MVA-BN in the Democratic Republic of the Congo
PACTR202511506487215Phase 3Recruiting
- Sponsor
- University of Antwerp
- Start
- Mar 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of JYNNEOS in mpox (4 arms), sponsored by University of Antwerp. Started Mar 2025; status: recruiting.
02
Drugs
JYNNEOS
03
Conditions
mpox
Beyond the preview
Go deeper on PACTR202511506487215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511506487215.